<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

FDA appoints Richard Pazdur as Director of CDER

PremiumThe Fly

7d ago

Perspective Therapeutics price target lowered to $13 from $14 at Oppenheimer

BMY

PremiumThe Fly

7d ago

Sanofi, Regeneron report all primary endpoints met in LIBERTY-AFRS-AIMS study

CATX

PremiumThe Fly

11d ago

Regeneron, Sanofi announces presentation of Phase 3 trial of Dupixent

REGN

PremiumThe Fly

11d ago

REGN

PremiumThe FlyDianthus price target raised to $62 from $60 at Oppenheimer

12d ago

DNTH

Novavax transfers U.S. marketing authorization for Nuvaxovid to Sanofi

The Fly

Novavax transfers U.S. marketing authorization for Nuvaxovid to Sanofi

14d ago

NVAX

FDA moves to accelerate biosimilar development, lower drug costs

The Fly

FDA moves to accelerate biosimilar development, lower drug costs

19d ago

Avidity Biosciences downgraded to Neutral from Buy at Roth Capital

BMY

PremiumThe Fly

22d ago

LLY

MRK

PremiumThe Fly

Sanofi assumed with a Buy at Jefferies

22d ago

Morning Movers: Intel, Ford rise after earnings

PremiumThe Fly

25d ago

PremiumThe Fly

Sanofi reports Q3 IRFS EPS EUR 2.30, up 2.2% reported

25d ago

PremiumThe FlySanofi expects FY25 business EPS growth at LDD percentage at CER

25d ago

ImageneBio initiated with an Outperform at Leerink

The Fly

ImageneBio initiated with an Outperform at Leerink

25d ago

IMA

Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects

Ratings

Sanofi: Buy Rating Affirmed on Strong Financials and Promising Growth Prospects

25d ago

Ventyx ‘unequivocally impressive data’ should spur Sanofi, says Clear Street

PremiumThe Fly

26d ago

Sanofi, Medidata expand partnership

VTYX

PremiumThe Fly

26d ago

Trump Trade: Trump administration prepares new probe into pharma prices

PremiumThe Fly

27d ago

Trump admin prepares new probe into U.S. pharma prices, FT says

PremiumThe Fly

27d ago

PremiumPre-EarningsSNYNF Earnings this Week: How Will it Perform?

27d ago

Sanofi announces Tzield sBLA accepted for expedited review by FDA

The Fly

Sanofi announces Tzield sBLA accepted for expedited review by FDA

29d ago

Sanofi says CHMP issues negative opinion on MAA for Rezurock

The Fly

Sanofi says CHMP issues negative opinion on MAA for Rezurock

1M ago